IndiaTickerAnalysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Source filing Company dossier
Tatva Chintan Pharma
NSE:TATVA · ISIN INE0GK401011
- Close
- ₹1,744.4 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Tatva Chintan Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement Under Regulation 30-Company UpdateBSE · exchange filing · pdf
Source filing Updates - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Archived filing Tatva Chintan Pharma Chem Ltd - 543321 - Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 30 June 2026BSE · financial results · pdf
Archived filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement Under Regulation 30-Capacity AdditionBSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Archived filing Investor Presentation - Tatva Chintan Pharma Chem LimitedNSE · investor presentation · pdf
Archived filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Archived filing Outcome of Board Meeting - Tatva Chintan Pharma Chem LimitedNSE · financial results · pdf
Archived filing Change in Director(s) - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · pdf
Archived filing Capacity addition - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · pdf
Archived filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Archived filing Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 17.07.2026BSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Archived filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Archived filing Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 17.07.2026BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · zip
Source filing Trading Window - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · pdf
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Tatva Chintan Pharma Chem LimitedNSE · exchange filing · pdf
Source filing